Cargando…

Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used new-generation drugs for depression. Depressive symptoms are thought to be closely related to neuroinflammation. In this study, we used up-to-date protocols of cultu...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jia-Hui, Liu, Rong-Pei, Peng, Yi-Man, Guo, Qing, Zhu, Lan-Bing, Lian, Yi-Zhi, Hu, Bei-Lei, Fan, Hui-Hui, Zhang, Xiong, Zhu, Jian-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890881/
https://www.ncbi.nlm.nih.gov/pubmed/33602262
http://dx.doi.org/10.1186/s12974-021-02097-z
_version_ 1783652588093177856
author He, Jia-Hui
Liu, Rong-Pei
Peng, Yi-Man
Guo, Qing
Zhu, Lan-Bing
Lian, Yi-Zhi
Hu, Bei-Lei
Fan, Hui-Hui
Zhang, Xiong
Zhu, Jian-Hong
author_facet He, Jia-Hui
Liu, Rong-Pei
Peng, Yi-Man
Guo, Qing
Zhu, Lan-Bing
Lian, Yi-Zhi
Hu, Bei-Lei
Fan, Hui-Hui
Zhang, Xiong
Zhu, Jian-Hong
author_sort He, Jia-Hui
collection PubMed
description BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used new-generation drugs for depression. Depressive symptoms are thought to be closely related to neuroinflammation. In this study, we used up-to-date protocols of culture and stimulation and aimed to understand how astrocytes respond to the antidepressants. METHODS: Primary astrocytes were isolated and cultured using neurobasal-based serum-free medium. The cells were treated with a cytokine mixture comprising complement component 1q, tumor necrosis factor α, and interleukin 1α with or without pretreatments of antidepressants. Cell viability, phenotypes, inflammatory responses, and the underlying mechanisms were analyzed. RESULTS: All the SSRIs, including paroxetine, fluoxetine, sertraline, citalopram, and fluvoxamine, show a visible cytotoxicity within the range of applied doses, and a paradoxical effect on astrocytic inflammatory responses as manifested by the promotion of inducible nitric oxide synthase (iNOS) and/or nitric oxide (NO) and the inhibition of interleukin 6 (IL-6) and/or interleukin 1β (IL-1β). The SNRI venlafaxine was the least toxic to astrocytes and inhibited the production of IL-6 and IL-1β but with no impact on iNOS and NO. All the drugs had no regulation on the polarization of astrocytic A1 and A2 types. Mechanisms associated with the antidepressants in astrocytic inflammation route via inhibition of JNK1 activation and STAT3 basal activity. CONCLUSIONS: The study demonstrated that the antidepressants possess differential cytotoxicity to astrocytes and function differently, also paradoxically for the SSRIs, to astrocytic inflammation. Our results provide novel pieces into understanding the differential efficacy and tolerability of the antidepressants in treating patients in the context of astrocytes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-021-02097-z.
format Online
Article
Text
id pubmed-7890881
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-78908812021-02-22 Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation He, Jia-Hui Liu, Rong-Pei Peng, Yi-Man Guo, Qing Zhu, Lan-Bing Lian, Yi-Zhi Hu, Bei-Lei Fan, Hui-Hui Zhang, Xiong Zhu, Jian-Hong J Neuroinflammation Research BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are commonly used new-generation drugs for depression. Depressive symptoms are thought to be closely related to neuroinflammation. In this study, we used up-to-date protocols of culture and stimulation and aimed to understand how astrocytes respond to the antidepressants. METHODS: Primary astrocytes were isolated and cultured using neurobasal-based serum-free medium. The cells were treated with a cytokine mixture comprising complement component 1q, tumor necrosis factor α, and interleukin 1α with or without pretreatments of antidepressants. Cell viability, phenotypes, inflammatory responses, and the underlying mechanisms were analyzed. RESULTS: All the SSRIs, including paroxetine, fluoxetine, sertraline, citalopram, and fluvoxamine, show a visible cytotoxicity within the range of applied doses, and a paradoxical effect on astrocytic inflammatory responses as manifested by the promotion of inducible nitric oxide synthase (iNOS) and/or nitric oxide (NO) and the inhibition of interleukin 6 (IL-6) and/or interleukin 1β (IL-1β). The SNRI venlafaxine was the least toxic to astrocytes and inhibited the production of IL-6 and IL-1β but with no impact on iNOS and NO. All the drugs had no regulation on the polarization of astrocytic A1 and A2 types. Mechanisms associated with the antidepressants in astrocytic inflammation route via inhibition of JNK1 activation and STAT3 basal activity. CONCLUSIONS: The study demonstrated that the antidepressants possess differential cytotoxicity to astrocytes and function differently, also paradoxically for the SSRIs, to astrocytic inflammation. Our results provide novel pieces into understanding the differential efficacy and tolerability of the antidepressants in treating patients in the context of astrocytes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12974-021-02097-z. BioMed Central 2021-02-18 /pmc/articles/PMC7890881/ /pubmed/33602262 http://dx.doi.org/10.1186/s12974-021-02097-z Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
He, Jia-Hui
Liu, Rong-Pei
Peng, Yi-Man
Guo, Qing
Zhu, Lan-Bing
Lian, Yi-Zhi
Hu, Bei-Lei
Fan, Hui-Hui
Zhang, Xiong
Zhu, Jian-Hong
Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation
title Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation
title_full Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation
title_fullStr Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation
title_full_unstemmed Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation
title_short Differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation
title_sort differential and paradoxical roles of new-generation antidepressants in primary astrocytic inflammation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890881/
https://www.ncbi.nlm.nih.gov/pubmed/33602262
http://dx.doi.org/10.1186/s12974-021-02097-z
work_keys_str_mv AT hejiahui differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation
AT liurongpei differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation
AT pengyiman differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation
AT guoqing differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation
AT zhulanbing differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation
AT lianyizhi differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation
AT hubeilei differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation
AT fanhuihui differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation
AT zhangxiong differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation
AT zhujianhong differentialandparadoxicalrolesofnewgenerationantidepressantsinprimaryastrocyticinflammation